Validfor develops an agentic digital validation platform purpose-built for life-sciences compliance teams. Using AI, the software automates validation workflows, structures regulatory documentation, and oversees the entire GxP compliance process, reducing manual effort and audit risk. Headquartered in Tallinn, Estonia, the company targets pharmaceutical, biotech, and medtech enterprises that must meet stringent regulatory standards. With its new capital, Validfor plans to accelerate product development, add autonomous testing features, and scale its engineering team. The firm aims to broaden the platform’s AI capabilities to serve global customers and modernize compliance across life sciences. Financially, the business is pre-revenue at the pre-seed stage and has secured $1.2 million in external funding to date.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2026